Da Vinci Systems Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2023 – 2032

Da Vinci Systems Market size is anticipated to witness substantial gains over 2023-2032, driven by the growing preference for minimally invasive surgeries. The Da Vinci surgical system is a minimally invasive surgical procedure that uses a few surgical incisions using high-definition 3D vision and tiny wristed robotic instruments which have better bending and rotating abilities than the human wrist.
 

This system offers myriad benefits such as less loss of blood, reduced pain, quick recovery, fewer hospital stays, less scarring, and reduced risk of infections as it employs fewer sutures and smaller incisions. 
 

Furthermore, increasing government oversight for the adoption of robots in healthcare is further augmenting Da Vinci systems marketgrowth. In fact, as per European regulations all surgical robots should go through a CE Mark certification under the European Medical Devices Directive. 
 

Despite a broad scope for product adoption, the rare risk associated with the malfunction of Da Vinci systems may constrain industry development. In such instances, doctors need to perform another surgery to fix the damaged tissue. Additionally, the surgeries performed using Da Vinci systems have a higher cost than conventional procedures, which may hold back its adoption. Moreover, these surgeries also take longer which may impede widescale industry deployment. 
 

Based on the component, Da Vinci systems market from the robotic systems segment is slated to witness lucrative gains through 2032. The robotic systems are majorly used for performing gynaecological, bariatric, cardiac, head and neck, and urological surgeries. These systems offer robotic precision and produce better results with less trauma to surrounding untreated tissue. They also have multiple benefits such as reduced hospitalization, quick recovery, minimal blood loss, and others. 
 

With respect to application, Da Vinci systems industry from the urologic surgery segment is anticipated to register substantial revenue by 2032. Da Vinci systems can be used for processes related to the urinary tract such as cystectomy, nephrectomy, and prostatectomy for removing cancerous tissues. The growing incidence of urinary tract disorders is likely to proliferate the demand for such systems. As per WHO, nearly 600 000 people are diagnosed with bladder cancer, annually, making it the 10th most common cancer type globally. 
 

 On the regional front, the Asia Pacific Da Vinci systems market is expected to depict considerable expansionover 2023-2032, on account of the rising spending by government on healthcare. In fact, in India's Union Budget for the year 2022-23, over USD 11.28 billion was allocated to the Ministry of Health and Family Welfare. The regional progression can also be credited to growing burden of chronic ailments in the region. As per the Journal of Thoracic Oncology, lung cancer is responsible for 8.1% of all cancer-related deaths in India. 
 

The Da Vinci systems industry leaders include Smith & Nephew plc, Stryker Corporation, Stryker plc, Hansen Medical Inc., and Mazor Robotics, among others. Many of these players are focusing on product innovations to consolidate their industry position.
 

What Information does this report contain?